Genomic Valley Biotech Stock Performance
as on August 4, 2026 at 8:00 pm IST
- ₹29.00₹29.00
52 Week's Low
52 Week's High
₹20.10₹53.49
30.69%
Downside
84.45%
Upside

Genomic Valley Biotech share price movements today
- Previous Close
- ₹28.00
- Open
- ₹29.00
- Volume
- 71.00
- Upper Circuit
- ₹29.40
- Lower Circuit
- ₹26.60
- Day's Low - High
- ₹29.00 - ₹29.00
- 52 Week Low - High
- ₹20.10 - ₹53.49
Genomic Valley Biotech Historical Returns
- 1 Month Return
- -8.02 %
- 3 Month Return
- + 15.46 %
- 1 Year Return
- -42.26 %
- 3 Year Return
- + 35.14 %
- 5 Year Return
- + 24.44 %
Genomic Valley Biotech Fundamentals
as on August 4, 2026 at 2:30 pm IST
Market Cap
₹8.55 Cr
Return on Equity (ROE)
9.69
PE Ratio (TTM)
311.11
Return on capital employed (ROCE)
12.11
Industry PE ratio
59.97
Beta (LTM)
0.36
P/B Ratio
4.59
Dividend Yield
0PEG Ratio
-296.3
Quarterly Earnings Growth YOY
-87.5
EPS (TTM)
0Book Value
0Genomic Valley Biotech Stock Valuation
as on August 4, 2026 at 2:30 pm IST
Genomic Valley Biotech in the last 5 years
Lowest (-1138.33x)
May 26, 2022
Industry (59.97x)
August 3, 2026
Today (311.11x)
August 3, 2026
Highest (679.78x)
June 28, 2024
Today’s Price to Earnings Ratio: 311.11x
Genomic Valley Biotech Technical Analysis
Track how Genomic Valley Biotech technical analysis has moved over time to understand its trends.
Technicals Summary
Bearish
Neutral
Bullish
Moving Averages
Bearish
Neutral
Bullish
Oscillators
Bearish
Neutral
Bullish
Overall
Oscillators
Name | Value | Action |
|---|---|---|
MACD level (12,26) | 0 | |
CCI (20) | 0 | Neutral |
RSI (14) | 100 | |
Momentum (10) | 0 | Neutral |
ADI (14) | 100 | Neutral |
Ultimate Oscillator (7,14,28) | 0 |
Moving Averages
Name | Value | Action |
|---|---|---|
SMA (20) | 29 | Neutral |
EMA (20) | 29 | Neutral |
VWMA (20) | 29 | Neutral |
SMA (50) | 29 | Neutral |
EMA (50) | 29 | Bullish |
SMA (200) | 29 | Neutral |
EMA (200) | 28.91 | Bullish |
KAMA (200) | 29 | Neutral |
DEMA (200) | 29.14 |
Genomic Valley Biotech Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Genomic Valley Biotech with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 8.55 | 4.89% | 0.00 | -1 | 2 | |
| NA | 638.00 | 12.91% | 0.52 | 8 | 149 | |
| NA | 62.71 | 14.13% | 0.53 | 1,188 | 30 | |
| NA | 232.71 | -15.93% | 0.65 | -1 | 406 | |
| NA | 20.10 | 131.31% | 0.00 | -2 | NA |
Genomic Valley Biotech Stock’s Investor Sentiment and Interest
Search interest for Genomic Valley Biotech Ltd Stock has decreased by -29% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Genomic Valley Biotech Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Genomic Valley Biotech Ltd Annual Profit & Loss
Figures in Rupees Crores
Genomic Valley Biotech Ltd Cash Flow
Figures in Rupees Crores
Genomic Valley Biotech Corporate Actions
View detailed summary of the earnings and dividend history of Genomic Valley Biotech.
Genomic Valley Biotech Ltd Earnings Results
Genomic Valley Biotech Ltd’s net profit jumped 87.5% since last year same period to ₹0.01Cr in the Q4 2025-2026. On a quarterly growth basis, Genomic Valley Biotech Ltd has generated -200% fall in its net profits since last 3-months.
Read More about Earnings Results
Insights on Genomic Valley Biotech Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers

In the last 3 years, Avanti Feeds Ltd has given 126.1% return, outperforming this stock by 91.0%
NO EFFECTAgainst Peers

In the last 1 year, Avanti Feeds Ltd has given 35.8% return, outperforming this stock by 78.1%
NO EFFECTRetail Holding Unchanged

Retail Investor holdings remained unchanged at 53.94% of holdings in Jun 2026 quarter
NO EFFECTPromoter Holding Unchanged

Promoters holdings remained unchanged at 46.06% of holdings in Jun 2026 quarter
NEGATIVE IMPACTPrice Dip

In the last 1 month, Genomic Valley stock has moved down by -8.0%
About Genomic Valley Biotech Ltd
Revenue: ₹0.04Cr as on March 2026 (Q4 FY26)
Net Profit: ₹0.01Cr as on March 2026 (Q4 FY26)
Chairperson Name: Yogesh Agrawal
| Organisation | Genomic Valley Biotech Ltd |
| Headquarters | New Delhi |
| Industry | Miscellaneous |
| CEO | Yogesh Agrawal |
| E-voting on shares | Click here to vote |
FAQs
What is Genomic Valley Biotech share price today?
Genomic Valley Biotech share price today stands at ₹29 as on . Genomic Valley Biotech share today touched a day high of ₹29 and a low of ₹29.
What is the 52 week high and 52 week low range for Genomic Valley Biotech share?
Genomic Valley Biotech touched a 52 week high of ₹53.49 and a 52 week low of ₹20.1. Genomic Valley Biotech share price today i.e. is trending at ₹29, which is -45.78% down from its 52 week high and 44.28% up from its 52 week low.
What is Genomic Valley Biotech's market capitalisation today?
Genomic Valley Biotech market capitalisation is ₹8.55 Cr as on .
How to buy Genomic Valley Biotech shares?
To buy Genomic Valley Biotech shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for 539206 or Genomic Valley Biotech Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Genomic Valley Biotech shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Genomic Valley Biotech trading volume today?
Genomic Valley Biotech trading volume is 71.00 as on . This means that 71.00 shares of Genomic Valley Biotech were bought and sold on the stock market during today's trading session.